For instance, IGF2BP1 typically promotes tumor growth in breast [67] and liver cancers [68], while IGF2BP2 and IGF2BP3 are involved in enhancing the proliferation and metastasis of certain cancers, such as colon cancer [69]. Here, IGF2BP3 is linked to malignant colon neoplasm.